Taggart McGurrin Warns: AI in Pharma Isn’t a Silver Bullet for Drug Pricing Woes
Experts have theorized that artificial intelligence will fundamentally alter the pharmaceutical sector by increasing the efficiency of drug development and lowering costs. And while its potential is exciting, the current…